Anumigilimab
Based on 1 Customer Validation
Anumigilimab (CSL-324) is an human IgG4 mAb against human granulocyte colony-stimulating factor (G-CSF) receptor. Anumigilimab can be used for increasing numbers of neutrophils at sites of inflammation.
For research use only. We do not sell to patients.
- Purity : 98.43%
- CAS No.: 2416593-08-1
- Molecular Weight:143.86 kDa
-
Storage:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
-
HY-P99031
MavrilimumabGM-CSF Inhibitor -
HY-114153C
PLX5622 in AIN-76A Diet (1200 ppm)PLX5622 Microglia Clearance Diet -
HY-109086
EdicotinibCSF-1R Inhibitor -
HY-114153
PLX5622CSF1R Inhibitor -
HY-12768
SotuletinibCSF-1R Inhibitor -
HY-10917
GW2580c-Fms Inhibitor -
HY-153920
PimicotinibCSF1R Inhibitor -
HY-12768A
Sotuletinib hydrochlorideCSF-1R Inhibitor -
HY-117244
AZD7507c-Fms Inhibitor -
HY-P99795
OtilimabAnti-GM-CSF Antibody -
HY-112451
cFMS Receptor Inhibitor IIc-Fms Inhibitor -
HY-122906
JTE-952CSF-1R/cFMS Inhibitor
Biological Activity
Description
Isotype
Human IgG4 kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
CSF3R
In Vitro
Anumigilimab (0-100 nM, 48h) inhibits the activation of JAK-1/2 by blocking the binding of G-CSF to G-CSFR, thereby inhibiting the phosphorylation of STAT3 and reducing the proliferation and colony formation of neutrophils[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:human neutrophils isolated from human peripheral blood
-
Concentration:0-100 nM
-
Incubation Time:48 h
-
Result:Inhibited cell viability.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Cynomolgus macaque models[3]
-
Dosage:0.1-10 mg/kg
-
Administration:iv, single dose
-
Result:Controled G-CSF mediated neutrophilia in cynomolgus macaque models without causing neutropenia.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Gene ID
Accession
Conjugated
Unconjugated
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Human IgG4 kappa
Application
ELISA, FACS, Functional assay
Verified Bioactivity
-
Flow Cytometry analysis of Ramos cells labelling CSF3R (red) with Anumigilimab (anti-CSF3R) (HY-P99440). Goat Anti-Human IgG (Alexa Fluor 488) (HY-P83776) at a dilution of 1/1000 was used as the secondary antibody. Blue-Human IgG4 (S228P) kappa (HY-P99003). Black-Unlabelled control, cells without incubation with primary antibody.
Chemical Information
-
CAS No. 2416593-08-1
-
Appearance Liquid
-
Molecular Weight 143.86 kDa
-
Color Colorless to light yellow
-
SMILES
[Anumigilimab]
-
Synonyms
CSL-324
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (260 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
[1]. Markota Čagalj A, et al. New and Emerging Targeted Therapies for Hidradenitis Suppurativa. Int J Mol Sci. 2022 Mar 29;23(7):3753. [Content Brief]
[2]. Rosales Santillan M, et al. Biologic therapies for the treatment of hidradenitis suppurativa. Expert Opin Biol Ther. 2020 Jun;20(6):621-633. [Content Brief]
[3]. Scalzo-Inguanti K, et al., A neutralizing anti-G-CSFR antibody blocks G-CSF-induced neutrophilia without inducing neutropenia in nonhuman primates. J Leukoc Biol. 2017 Aug;102(2):537-549. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Anumigilimab Related Classifications
HY-P99440 Related Classifications
Powered by Bioz